Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
LSU Health Sciences Center - New Orleans
mi
from
New Orleans, LA
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
LSU Health Sciences Center - New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt Health System
mi
from
Baltimore, MD
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
State University Of New York
mi
from
Buffalo, NY
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
State University Of New York
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of America Inc
mi
from
Hickory, NC
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of America Inc
mi
from
Hickory, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Mental Health Center Prof. Dr. Ivan Temkov
mi
from
Bourgas,
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Mental Health Center Prof. Dr. Ivan Temkov
mi
from
Bourgas,
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated:  12/31/1969
Metropolitan Neuro Behavioral Institute
mi
from
Chandler, AZ
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
Status: Enrolling
Updated: 12/31/1969
Metropolitan Neuro Behavioral Institute
mi
from
Chandler, AZ
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Melmed Center
mi
from
Scottsdale, AZ
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Melmed Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
AVIDA, Inc.
mi
from
Newport Beach, CA
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
AVIDA, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Duke Child and Family Study Center
mi
from
Durham, NC
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
The Neuropsychiatric Clinic at Carolina Partners
mi
from
Raleigh, NC
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
The Neuropsychiatric Clinic at Carolina Partners
mi
from
Raleigh, NC
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Bradenton, FL
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Midwest Research Group
mi
from
Saint Charles, MO
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/31/1969
Seattle Children's
mi
from
Seattle, WA
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
An Exploratory Study to Assess the Sustained Effects of Digital Therapy in Pediatric Subjects 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/31/1969
Seattle Children's
mi
from
Seattle, WA
Click here to add this to my saved trials
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD: A Randomized Controlled Trial in Active Duty Military Personnel
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD: A Randomized Controlled Trial in Active Duty Military Personnel
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
MDMA-assisted and Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads With One Member With Chronic PTSD
Phase 1/2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  12/31/1969
Offices of Michael Mithoefer
mi
from
Mount Pleasant, SC
MDMA-assisted and Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads With One Member With Chronic PTSD
Phase 1/2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 12/31/1969
Offices of Michael Mithoefer
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Autism Oxytocin Brain Project
Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Autism Oxytocin Brain Project
Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Aripiprazole in Children With Autism: A Pilot Study
Aripiprazole in Children With Autism: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Drexel University College of Medicine at Friends Hospital
mi
from
Philadelphia, PA
Aripiprazole in Children With Autism: A Pilot Study
Aripiprazole in Children With Autism: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine at Friends Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
e-Unstuck: Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  12/31/1969
Children's National Health System
mi
from
Rockville, MD
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
e-Unstuck: Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Children's National Health System
mi
from
Rockville, MD
Click here to add this to my saved trials
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
e-Unstuck: Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  12/31/1969
3C Institute
mi
from
Durham, NC
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
e-Unstuck: Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
3C Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Mobile Enhancement of Motivation in Schizophrenia
Mobile Enhancement of Motivation in Schizophrenia: A Pilot Trial of a Personalized Text Message Intervention for Motivation Deficits
Status: Enrolling
Updated:  12/31/1969
Midtown Community Mental Health Center
mi
from
Indianapolis, IN
Mobile Enhancement of Motivation in Schizophrenia
Mobile Enhancement of Motivation in Schizophrenia: A Pilot Trial of a Personalized Text Message Intervention for Motivation Deficits
Status: Enrolling
Updated: 12/31/1969
Midtown Community Mental Health Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
Addiction Treatment in Russia: Oral and Depot Naltrexone
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
Addiction Treatment in Russia: Oral and Depot Naltrexone
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
Addiction Treatment in Russia: Oral and Depot Naltrexone
Status: Enrolling
Updated:  12/31/1969
Pavlov Medical University
mi
from
St. Petersburg,
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
Addiction Treatment in Russia: Oral and Depot Naltrexone
Status: Enrolling
Updated: 12/31/1969
Pavlov Medical University
mi
from
St. Petersburg,
Click here to add this to my saved trials
Varenicline Treatment for Cannabis Use Disorder
Advancing Varenicline as a Treatment for Cannabis Use Disorder
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Varenicline Treatment for Cannabis Use Disorder
Advancing Varenicline as a Treatment for Cannabis Use Disorder
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Treatment and Research Center
mi
from
La Jolla, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Treatment and Research Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Lakeland, FL
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
CODA, Inc.
mi
from
Portland, OR
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
CODA, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated:  12/31/1969
George Washington University
mi
from
Washington,
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Status: Enrolling
Updated: 12/31/1969
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Engineering an Online STI Prevention Program
Engineering an Online STI Prevention Program
Status: Enrolling
Updated:  12/31/1969
Fresno State University
mi
from
Fresno, CA
Engineering an Online STI Prevention Program
Engineering an Online STI Prevention Program
Status: Enrolling
Updated: 12/31/1969
Fresno State University
mi
from
Fresno, CA
Click here to add this to my saved trials